A loss of genetic information has been postulated to play a key role in the development of human cancer. This concept has been supported by several types of investigations. Somatic cell hybrids between tumorigenic human cancer cells and their normal cellular counterparts are totally suppressed for tumor-forming ability indicating that tumorigenicity behaves as a recessive genetic trait. Furthermore specific chromosomal deletions have been identified in certain types of pediatric cancers implying the loss of certain critical genes during development of these tumors. Despite this strong circumstantial evidence for the existence of recessive cancer genes, little is known about the functions, number or locations of these genes. One appraoch to characterizing these recessive cancer genes is to study whole cell hybrids between different pediatric tumor cells and microcell hybrids into which normal human chromosomes have been introduced. A complementation analysis using whole cell hybrids would determine how many different cancer genes are invoved in the development of human cancer. The location of these genes can be revealed by the introductin of individual chromosomes into pediatric cancer cells. Further localization of the sites of these genes can be accomplished by the use of chromosomal transloations and RFLP analyses. The hybrid cell will also be characterized for in vitro growth parameters associated with transformation including serum growth factor requirements, anchorage independent growth, fibronectin expression and production of plasminogen activator. Tumorigenic potential will be assayed by the injection of these cells into nu/nu mice. Cellular protein synthesis will be characterized by two- dimensional polyacrylamide electrophoresis. These studies will provide new insights into the functions of recessive cancer genes in human cells and serve as the basis for future molecular cloning studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA044470-03
Application #
3187101
Study Section
Pathology B Study Section (PTHB)
Project Start
1988-03-01
Project End
1991-11-30
Budget Start
1990-04-01
Budget End
1991-11-30
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Coleman, W B; Ricketts, S L; Borchert, K M et al. (1999) Induction of rat WT1 gene expression correlates with human chromosome 11p11.2-p12-mediated suppression of tumorigenicity in rat liver epithelial tumor cell lines. Int J Oncol 14:957-63
Isaacs, J S; Chiao, C; Merrick, B A et al. (1997) p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Res 57:2986-92
Hall, I J; Gioeli, D; Weissman, B E et al. (1997) Identification of additional complementation groups that regulate genomic instability. Genes Chromosomes Cancer 20:103-12
Yang, X; Welch, D R; Phillips, K K et al. (1997) KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 119:149-55
Isaacs, J S; Chen, P; Garza, A et al. (1997) Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids. Oncogene 14:1669-78
Lee, J H; Miele, M E; Hicks, D J et al. (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88:1731-7
Coleman, W B; McCullough, K D; Esch, G L et al. (1995) Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2-p12 region of human chromosome 11. Mol Carcinog 13:220-32
McMaster, M L; Gessler, M; Stanbridge, E J et al. (1995) WT1 expression alters tumorigenicity of the G401 kidney-derived cell line. Cell Growth Differ 6:1609-17
Chen, P; Lin, H H; Weissman, B E (1995) A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by monochromosome transfer. Oncogene 10:577-86
Welch, D R; Chen, P; Miele, M E et al. (1994) Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9:255-62

Showing the most recent 10 out of 15 publications